Diagnostic Value of ANA Titer, Anti-ds-DNA, Anti-nRNPSm, and Sm Antibodies in Early Atypical Systemic Lupus Erythematosus.

IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Jianqiao Zhang, Meichen Liu, Qing Liu, Dong Chen, Meng Zhang
{"title":"Diagnostic Value of ANA Titer, Anti-ds-DNA, Anti-nRNPSm, and Sm Antibodies in Early Atypical Systemic Lupus Erythematosus.","authors":"Jianqiao Zhang, Meichen Liu, Qing Liu, Dong Chen, Meng Zhang","doi":"10.12669/pjms.42.9.14966","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the diagnostic value of antinuclear antibody(ANA) titer, anti-double-stranded DNA(anti-ds-DNA) antibody, anti-nuclear ribonucleoprotein/Smith(anti-nRNPSm) antibody, and Smith (Sm) antibody for early atypical systemic lupus erythematosus(SLE).</p><p><strong>Methodology: </strong>This was a retrospective study. Forty-nine patients diagnosed with early atypical SLE admitted to Affiliated Hospital of Hebei University between January 2023 to June 2025 were assigned to Group-A, and 66 patients with other autoimmune diseases admitted during the same period were enrolled in Group-B. Compared the results of ANA, anti-ds-DNA, anti-nRNPSm and Sm antibody tests between the two groups, and analyzed the diagnostic value of the individual indicators and their combined detection for early atypical SLE.</p><p><strong>Results: </strong>There were statistically significant differences in the results of ANA, anti-ds-DNA, anti-nRNPSm and Sm antibodies between the two groups(P<0.05). Multivariate Logistic regression analysis confirmed that ANA, anti-ds-DNA, anti-nRNPSm and Sm were independent influencing factors for early atypical SLE (<i>P</i><0.05). ROC curve analysis showed that the AUC of combined diagnosis was 0.856, with a predictive sensitivity of 87.8%, a specificity of 71.2%, and a predictive probability of 0.79. Significant differences in AUC were observed between ANA and anti-ds-DNA antibody, Sm antibody, or the four-antibody combination(<i>P</i><0.05); between anti-ds-DNA antibody and the four-antibody combination(<i>P</i><0.05); and between anti-nRNPSm antibody, Sm antibody and the four-antibody combination(<i>P</i><0.05).</p><p><strong>Conclusion: </strong>ANA, anti-ds-DNA, anti-nRNPSm and Sm antibodies are major independent influencing factors for early atypical SLE. Combined detection of these indicators may effectively improve the diagnostic value for this disease.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"42 9","pages":"2318-2323"},"PeriodicalIF":1.6000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13624448/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12669/pjms.42.9.14966","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the diagnostic value of antinuclear antibody(ANA) titer, anti-double-stranded DNA(anti-ds-DNA) antibody, anti-nuclear ribonucleoprotein/Smith(anti-nRNPSm) antibody, and Smith (Sm) antibody for early atypical systemic lupus erythematosus(SLE).

Methodology: This was a retrospective study. Forty-nine patients diagnosed with early atypical SLE admitted to Affiliated Hospital of Hebei University between January 2023 to June 2025 were assigned to Group-A, and 66 patients with other autoimmune diseases admitted during the same period were enrolled in Group-B. Compared the results of ANA, anti-ds-DNA, anti-nRNPSm and Sm antibody tests between the two groups, and analyzed the diagnostic value of the individual indicators and their combined detection for early atypical SLE.

Results: There were statistically significant differences in the results of ANA, anti-ds-DNA, anti-nRNPSm and Sm antibodies between the two groups(P<0.05). Multivariate Logistic regression analysis confirmed that ANA, anti-ds-DNA, anti-nRNPSm and Sm were independent influencing factors for early atypical SLE (P<0.05). ROC curve analysis showed that the AUC of combined diagnosis was 0.856, with a predictive sensitivity of 87.8%, a specificity of 71.2%, and a predictive probability of 0.79. Significant differences in AUC were observed between ANA and anti-ds-DNA antibody, Sm antibody, or the four-antibody combination(P<0.05); between anti-ds-DNA antibody and the four-antibody combination(P<0.05); and between anti-nRNPSm antibody, Sm antibody and the four-antibody combination(P<0.05).

Conclusion: ANA, anti-ds-DNA, anti-nRNPSm and Sm antibodies are major independent influencing factors for early atypical SLE. Combined detection of these indicators may effectively improve the diagnostic value for this disease.

ANA滴度、抗ds- dna、抗nrnpsm和Sm抗体对早期非典型系统性红斑狼疮的诊断价值。
目的:探讨抗核抗体(ANA)滴度、抗双链DNA(抗ds-DNA)抗体、抗核核糖核蛋白/史密斯(抗nrnpsm)抗体、史密斯(Sm)抗体对早期非典型系统性红斑狼疮(SLE)的诊断价值。方法:这是一项回顾性研究。将2023年1月至2025年6月河北大学附属医院收治的49例早期非典型SLE患者分为a组,66例同期收治的其他自身免疫性疾病患者分为b组。比较两组患者ANA、抗ds- dna、抗nrnpsm、Sm抗体检测结果,分析单项指标及其联合检测对早期非典型SLE的诊断价值。结果:两组患者抗ANA、抗ds- dna、抗nrnpsm、Sm抗体检测结果(ppppp)比较,差异均有统计学意义。结论:抗ANA、抗ds- dna、抗nrnpsm、Sm抗体是早期非典型SLE的主要独立影响因素。这些指标的联合检测可有效提高本病的诊断价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pakistan Journal of Medical Sciences
Pakistan Journal of Medical Sciences 医学-医学:内科
CiteScore
4.10
自引率
9.10%
发文量
363
审稿时长
3-6 weeks
期刊介绍: It is a peer reviewed medical journal published regularly since 1984. It was previously known as quarterly "SPECIALIST" till December 31st 1999. It publishes original research articles, review articles, current practices, short communications & case reports. It attracts manuscripts not only from within Pakistan but also from over fifty countries from abroad. Copies of PJMS are sent to all the import medical libraries all over Pakistan and overseas particularly in South East Asia and Asia Pacific besides WHO EMRO Region countries. Eminent members of the medical profession at home and abroad regularly contribute their write-ups, manuscripts in our publications. We pursue an independent editorial policy, which allows an opportunity to the healthcare professionals to express their views without any fear or favour. That is why many opinion makers among the medical and pharmaceutical profession use this publication to communicate their viewpoint.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书